KA

Kidney Cancer Association

Kidney Cancer Association (KCA) Market Research Report






Company Overview



Name


Kidney Cancer Association (KCA)

Mission


To be a global community dedicated to serving and empowering patients and caregivers, and leading change through advocacy, research, and education.

Vision


To be the universal leader in finding the cure for kidney cancer.

Founding


  • Year Founded: 1990

  • Founders: Eugene P. Schonfeld and a small group of patients and doctors


Headquarters


  • Location: 2777 Allen Parkway Suite 424, Houston, TX 77019


Key People


  • Founder: Eugene P. Schonfeld

  • Board Chairman (Deceased): Dr. Christopher G. Wood


Number of Employees


No information is available

Revenue


No information is available

Known For


  • Promoting scientific advances through annual research symposiums and a robust grant program.

  • Participating in legislative advocacy.

  • Serving as an educational and resource hub for patients, caregivers, and anyone impacted by kidney cancer.





Products



Products Offered


  • Research Grants and Funding:

  • Description: Financial support for research projects related to kidney cancer.

  • Key Features: Annual grants, robust grant program.


  • Educational Resources:

  • Description: Information and educational material for patients, caregivers, and medical professionals.

  • Key Features: Patient navigator program, clinical advisory resources.


  • Legislative Advocacy:

  • Description: Engagement in legislative activities to promote kidney cancer research and patient care.

  • Key Features: Advocacy campaigns, legislative support.


  • Annual Research Symposiums:

  • Description: Events to promote kidney cancer research.

  • Key Features: Two annual symposiums, international collaboration.





Recent Developments



New Products/Partnerships


  • Collaboration with Tempus (May 30, 2024):

  • Purpose: Support postdoctoral research fellowship on AI and precision medicine in kidney cancer.

  • Key Feature: Accelerating research through AI.


  • Strategic Partnership with xCures (May 28, 2024):

  • Purpose: Empower patients with greater control over their health data and accelerate discovery of treatments.

  • Key Feature: AI-driven research initiatives.


Recent Features/Initiatives


  • Patient Assistance Fund (March 26, 2024):

  • Description: Financial support for patients and families.

  • Key Development: $10,000 donation from the Ferrell Foundation.


  • Chromophobe RCC-specific Grant (March 4, 2024):

  • Description: Co-sponsored research award with the Chromophobe and Oncocytic Tumor Alliance.

  • Key Development: Focused on differentiating biological hallmarks and treatments.


Awards and Recognitions


  • Nicholas J. Vogelzang Humanitarian Award:

  • Recipient: Dr. Nizar M. Tannir

  • Date: November 6, 2023

  • Recognition: Outstanding service and compassion for patients.


Affiliate Partnerships


  • Wilms Cancer Foundation (August 14, 2023):

  • Judy Nicholson Kidney Cancer Foundation (July 21, 2023):


Key Developments


  • In Memoriam: Dr. Christopher G. Wood (November 3, 2021):

  • Impact: Dr. Wood's significant contributions and leadership within the kidney cancer community.





Contact Information



General Contact


  • Mailing Address:

  • Kidney Cancer Association

  • 2777 Allen Parkway Suite 424

  • Houston, TX 77019


  • Telephone:

  • USA: 1-800-850-9132

  • International: +1-847-332-1051


  • Email:

  • General: office@kidneycancer.org

  • Patients: Patient Navigator Program

  • Donors: donations@kidneycancer.org

  • Physicians and Industry: clinicianprograms@kidneycancer.org


Donation Address


  • Secure Lock-box:

  • Kidney Cancer Association

  • PO Box 676226

  • Dallas, TX 75267-6226





End of Report